Sg Americas Securities, LLC Avrobio, Inc. Transaction History

Sg Americas Securities, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 29, 2022	SELL	$1.29 - $4.04 $13,489 - $42,246	-10,457 Closed	0 $0
Q4 2021 Feb 07, 2022	SELL	$3.45 - $6.05 $55,441 - $97,223	-16,070 Reduced 60.58%	10,457 $40,000
Q3 2021 Nov 01, 2021	BUY	$5.53 - $9.28 $146,694 - $246,170	26,527 New	26,527 $148,000
Q2 2021 Aug 12, 2021	SELL	$7.84 - $12.6 $63,276 - $101,694	-8,071 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$10.54 - $19.3 $85,068 - $155,770	8,071 New	8,071 $102,000
Q3 2020 Nov 09, 2020	SELL	$12.99 - $19.41 $131,705 - $196,797	-10,139 Closed	0 $0
Q2 2020 Jul 20, 2020	BUY	$12.19 - $22.96 $37,179 - $70,028	3,050 Added 43.02%	10,139 $177,000
Q1 2020 Apr 30, 2020	BUY	$10.08 - $27.21 $71,457 - $192,891	7,089 New	7,089 $110,000

559K

Ticker AVRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,773,900
Description
AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose worldwide. Its gene therapies employ hematopoietic stem cells that are collected from patients and modified with a lentiviral vector to insert functional copies of the gene that is defective in the...

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg Americas Securities, LLC with notifications on news.